Gamma-delta hepatosplenic T-cell lymphoma. Description of a case with immunophenotypic and molecular follow-up successfully treated with chemotherapy alone

Leukemia and Lymphoma

Volumn 47, Issue 2, 2006, Pages 333-336

  Moleti, Maria Luisa ^a   Testi, Anna Maria ^a   Giona, Fiorina ^a   Amendola, Angela ^a   Palumbo, Giovanna ^a   Uccini, Stefania ^a   Starza, Irene Della ^a   de Propris, Maria Stefania ^a   Guarini, Anna ^a   Foà, Robin ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Chemotherapy; Gamma delta hepatosplenic T cell lymphoma; TCR gamma chain gene

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; ETOPOSIDE; FOLINIC ACID; IFOSFAMIDE; METHOTREXATE; PREDNISONE; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; VINCRISTINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; FOLLOW UP; GOOD GENERAL CONDITION; HUMAN; IMMUNOPHENOTYPING; MALE; MINIMAL RESIDUAL DISEASE; OUTCOMES RESEARCH; PATIENT MONITORING; PRIORITY JOURNAL; T CELL LYMPHOMA;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HEPATOMEGALY; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, T-CELL; MALE; NEOPLASM, RESIDUAL; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; REMISSION INDUCTION; SENSITIVITY AND SPECIFICITY; SPLENOMEGALY; TREATMENT OUTCOME;

EID: 30644459887     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190500293321     Document Type: Article

References (17)

1. Harris, N and Jaffe, E and Stein, H and Banks, P and Chan, J and Cleary, M and (1994) A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group Blood 84, pp. 1361 - 1392.
2. Wong, K and Chan, J and Matutes, E and McCarthy, K and Ng, C and Chan, C and (1995) Hepatosplenic gamma delta T-cell lymphoma: A distinctive aggressive lymphoma type American Journal of Surgical Pathology, 19, pp. 718 - 726.
3. Belhadj, K and Reyes, F and Farcet, J and Tilly, H and Bastard, C and Angonin, R and (2003) Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: Report of a series of 21 patients Blood, 102, pp. 4261 - 4269.
4. Weidmann, E. (2000) Hepatosplenic T-cell lymphoma: A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990 Leukemia, 14, pp. 991 - 997.
5. Zinzani, P and Tani, M and Molinari, A and Stefoni, V and Zuffa, E and Alinari, L and (2002) Ifosfamide, epirubicin and etoposide regimen as salvage and mobilizing therapy for relapsed/refractory lymphoma patients Haematologica, 87, pp. 816 - 821.
6. Klimo, P and Connors, J. (1985) MACOP-B chemotherapy for the treatment of advanced diffuse large cell lymphoma Annals of Internal Medicine, 102, pp. 596 - 602.
7. Farcet, J and Gaulard, P and Marolleau, J and Le Couedic, J and Henni, T and Gourdin, M and (1990) Hepatosplenic T-cell lymphoma: Sinusal/ sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta Blood, 75, pp. 2213 - 2219.
8. Vega, F and Medeiros, L and Bueso-Ramos, C and Jones, D and Lai, R and Luthra, R and Abruzzo, L. (2001) Hepatosplenic gamma/delta T-cell lymphoma in bone marrow: A sinusoidal neoplasm with blastic cytologic features American Journal of Clinical Pathology, 116, pp. 410 - 419.
9. Cooke, C and Krenacs, L and Stetler-Stevenson, M and Greiner, T and Raffled, M and Kingma, D and (1996) Hepatosplenic T-cell lymphoma: A distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin Blood, 88, pp. 4265 - 4274.
10. Salhany, K and Feldman, M and Kahn, M and Peritt, D and Schretzenmair, R and Wilson, D and (1997) Hepatosplenic gamma delta T-cell lymphoma: ultrastructural, immunophenotypic, and functional evidence for cytotoxic T lymphocyte differentiation Human Pathology, 28, pp. 674 - 685.
11. Jonveaux, P and Daniel, M and Martel, V and Maarek, O and Berger, R. (1996) Isochromosome 7q and trisomy 8 hepatosplenic T gamma/delta lymphoma Leukemia, 10, pp. 1453 - 1455.
12. Salhany, K and Feldman, M and Peritt, D and Nowell, P. (1997) Cytotoxic T-lymphocyte differentiation and are consistent primary, non-random chromosomal abnormalities associated with cytogenetic alterations in gamma delta hepatosplenic T-cell lymphoma and posttransplant lymphoproliferative disorders Blood, 89, pp. 3490 - 3491.
13. Khan, W and Yu, L and Eisenbrey, A and Crisan, D and al Saadi, A and Davis, B and (2001) Hepatosplenic gamma/delta T-cell lymphoma in immunocompromised patients: Report of two cases and review of literature American Journal of Clinical Pathology, 116, pp. 41 - 50.
14. Gassas, A and Kirby, M and Weitzman, S and Ngan, B and Abla, O and Doyle, J. (2004) Hepatosplenic gammadelta T-cell lymphoma in a 10 year old boy successfully treated with hemopoietic bone marrow transplantation American Journal of Hematology, 75, pp. 113 - 114.
15. Ooi, J and Iseki, T and Adachi, D and Yamashita, T and Tomonari, A and Tojo, A and (2001) Successful allogeneic bone marrow transplantation for hepatosplenic T-cell lymphoma Haematologica, 86, pp. E25.
16. Grigg, A. (2001) 2′-Deoxycoformycin for hepatosplenic T-cell lymphoma Leukemia and Lymphoma, 42, pp. 797 - 799.
17. Iannitto, E and Barbera, V and Quintini, G and Cirrincione, S and Leone, M. (2002) Hepatosplenic T-cell lymphoma: Complete response induced by treatment with pentostatin British Journal of Haematology, 117, pp. 995 - 996.